Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Total Current Liabilities (2016 - 2025)

United States Antimony's Total Current Liabilities history spans 15 years, with the latest figure at $6.3 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 160.37% year-over-year to $6.3 million; the TTM value through Sep 2025 reached $6.3 million, up 160.37%, while the annual FY2024 figure was $4.0 million, 346.42% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $6.3 million at United States Antimony, down from $8.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $8.0 million in Q2 2025 and bottomed at $897458.0 in Q4 2023.
  • The 5-year median for Total Current Liabilities is $1.8 million (2021), against an average of $2.5 million.
  • The largest annual shift saw Total Current Liabilities tumbled 59.57% in 2023 before it soared 538.66% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $2.1 million in 2021, then rose by 7.2% to $2.2 million in 2022, then crashed by 59.57% to $897458.0 in 2023, then surged by 346.42% to $4.0 million in 2024, then skyrocketed by 56.29% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for UAMY's Total Current Liabilities are $6.3 million (Q3 2025), $8.0 million (Q2 2025), and $4.7 million (Q1 2025).